Liver and insulin resistance: New wine in old bottle!!!

Ader, 2014, Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog, Obesity, 22, 1238, 10.1002/oby.20625 Aguirre, 2002, Phosphorylation of Ser 307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action, J. Biol. Chem., 277, 1531, 10.1074/jbc.M101521200 Ahmadian, 2013, PPARγ signaling and metabolism: the good, the bad and the future, Nat. Med., 19, 557, 10.1038/nm.3159 Akira, 2004, Toll-like receptor signalling, Nat. Rev. Immunol., 4, 499, 10.1038/nri1391 Alberti, 2009, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 Almind, 1996, A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies, J. Clin. Investig., 97, 2569, 10.1172/JCI118705 An, 2010, TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle, Diabetes, 59, 1358, 10.2337/db09-1266 Andreozzi, 2011, Increased levels of the Akt-specific phosphatase PHdomain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance, Diabetologia, 54, 1879, 10.1007/s00125-011-2116-6 Archer, 1975, Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction, J. Clin. Investig., 55, 166, 10.1172/JCI107907 Arkan, 2005, IKK-beta links inflammation to obesity-induced insulin resistance, Nat. Med., 11, 191, 10.1038/nm1185 Armstrong, 2016, Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study, Lancet, 387, 679, 10.1016/S0140-6736(15)00803-X Armstrong, 2013, Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program, Aliment 811 Pharmacol. Ther., 37, 234, 10.1111/apt.12149 Aroor, 2015, Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function, Diabetes, 64, 1988, 10.2337/db14-0804 Barzilai, 1993, Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin, J. Biol. Chem., 268, 25019, 10.1016/S0021-9258(19)74566-9 Baumeier, 2017, Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease, Mol. Metab., 6, 1254, 10.1016/j.molmet.2017.07.016 Bayascas, 2010, PDK1: the major transducer of PI 3-kinase actions, Curr. Top. Microbiol. Immunol., 346, 9 Bazotte, 2014, Insulin resistance in the liver: deficiency or excess of insulin?, Cell Cycle, 13, 2494, 10.4161/15384101.2014.947750 Belman, 2015, Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment, J. Biol. Chem., 290, 4447, 10.1074/jbc.M114.603977 Benhamed, 2012, The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Investig., 122, 2176, 10.1172/JCI41636 Berger, 2003, Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator, Mol. Endocrinol., 17, 662, 10.1210/me.2002-0217 Biddinger, 2008, Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis, Cell Metabol., 7, 125, 10.1016/j.cmet.2007.11.013 Birkenfeld, 2014, Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes, Hepatology, 59, 713, 10.1002/hep.26672 Block, 1991, Skeletal muscle insulin receptor kinase. Effects of substrate inhibition and diabetes, Diabetes, 40, 1691, 10.2337/diab.40.12.1691 Blouin, 2010, Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling, Diabetes, 59, 600, 10.2337/db09-0897 Boden, 2002, FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis, Am. J. Physiol. Endocrinol. Metab., 283, E12, 10.1152/ajpendo.00429.2001 Boucher, 2014, Insulin receptor signaling in normal and insulin-resistant states, Cold Spring Harb. Perspect. Biol., 6, 10.1101/cshperspect.a009191 Boyle, 2010, Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence, Popul. Health Metrics, 8, 29, 10.1186/1478-7954-8-29 Bozulic, 2008, PKBa/Akt1 acts downstream of DNA-PK in the DNA double strand break response and promotes survival, Mol. Cell, 30, 203, 10.1016/j.molcel.2008.02.024 Brognard, 2008, PHLiPPing the switch on Akt and protein kinase C signaling, Trends Endocrinol. Metab., 19, 223, 10.1016/j.tem.2008.04.001 Brown, 2010, CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance, J. Lipid Res., 51, 3306, 10.1194/jlr.M010256 Brown, 2008, Selective versus total insulin resistance: a pathogenic paradox, Cell Metabol., 7, 95, 10.1016/j.cmet.2007.12.009 Brüning, 1998, A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance, Mol. Cell, 2, 559, 10.1016/S1097-2765(00)80155-0 Bryant, 2011, SNA RE proteins underpin insulin-regulated GLUT4 traffic, Traffic, 12, 657, 10.1111/j.1600-0854.2011.01163.x Burchell, 1985, Rat hepatic microsomal glucose-6-phosphatase protein levels are increased in streptozotocin-induced diabetes, Diabetologia, 28, 852, 10.1007/BF00291077 Cai, 2005, Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NFkappaB, Nat. Med., 11, 183, 10.1038/nm1166 Cariou, 2004, Increased adipose tissue expression of Grb14 in several models of insulin resistance, FASEB J., 18, 965, 10.1096/fj.03-0824fje Cariou, 2006, The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice, J. Biol. Chem., 281, 11039, 10.1074/jbc.M510258200 Caron, 2015, The roles of mTOR complexes in lipid metabolism, Annu. Rev. Nutr., 35, 321, 10.1146/annurev-nutr-071714-034355 Carracedo, 2008, The PTEN-PI3K pathway: of feedbacks and cross-talks, Oncogene, 27, 5527, 10.1038/onc.2008.247 Cases, 2001, Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members, J. Biol. Chem., 276, 38870, 10.1074/jbc.M106219200 Chakraborty, 2010, Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain, Cell, 143, 897, 10.1016/j.cell.2010.11.032 Chan, 2013, Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose fed mice despite increased endoplasmic reticulum stress, Diabetes, 62, 2095, 10.2337/db12-1397 Cheng, 2015, PPP2R5C couples hepatic glucose and lipid homeostasis, PLoS Genet., 11, 10.1371/journal.pgen.1005561 Cho, 2006, Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling, Cell Metabol., 3, 367, 10.1016/j.cmet.2006.03.006 Cho, 2001, Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB b), Science, 292, 1728, 10.1126/science.292.5522.1728 Choi, 2007, Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance, J. Biol. Chem., 282, 22678, 10.1074/jbc.M704213200 Choi, 2011, Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation, Nature, 477, 477, 10.1038/nature10383 Choi, 2014, Revisiting PPARγ as a target for the treatment of metabolic disorders, BMB Rep., 47, 599, 10.5483/BMBRep.2014.47.11.174 Christensen, 1998, Membrane receptors for endocytosis in the renal proximal tubule, Int. Rev. Cytol., 180, 237, 10.1016/S0074-7696(08)61772-6 Cipriani, 2010, FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats, J. Lipid Res., 51, 771, 10.1194/jlr.M001602 Clement, 2001, The lipid phosphatase SHIP2 controls insulin sensitivity, Nature, 409, 92, 10.1038/35051094 Cochran, 2005, The use of U-500 in patients with extreme insulin resistance, Diabetes Care, 28, 1240, 10.2337/diacare.28.5.1240 Cook, 2015, Pathogenesis of selective insulin resistance in isolated hepatocytes, J. Biol. Chem., 290, 13972, 10.1074/jbc.M115.638197 Cooney, 2004, Improved glucose homeostasis and enhanced insulin signaling in Grb14-deficient mice, EMBO J., 23, 582, 10.1038/sj.emboj.7600082 Cozzone, 2008, Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients, Diabetologia, 51, 512, 10.1007/s00125-007-0913-8 Cusi, 2000, Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle, J. Clin. Investig., 105, 311, 10.1172/JCI7535 Cusi, 2018, Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme, Diabet. Med., 35, 1434, 10.1111/dme.13697 De Fea, 1997, Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612, Biochemistry, 36, 12939, 10.1021/bi971157f De Fronzo, 2004, Dysfunctional fat cells, lipotoxicity and type 2 diabetes, Int. J. Clin. Pract. Suppl., 143, 9, 10.1111/j.1368-504X.2004.00389.x DeFronzo, 2009, Skeletal muscle insulin resistance is the primary defect in type 2 diabetes, Diabetes Care, 32, S157, 10.2337/dc09-S302 DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes, Diabetes Rev., 5, 177 Degerman, 2011, From PDE3B to the regulation of energy homeostasis, Curr. Opin. Pharmacol., 11, 676, 10.1016/j.coph.2011.09.015 Delibegovic, 2009, Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress, Diabetes, 58, 590, 10.2337/db08-0913 Diggs-Andrews, 2010, Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia, Diabetes, 59, 2271, 10.2337/db10-0401 Dohm, 1991, Decreased expression of glucose transporter in muscle from insulin-resistant patients, Am. J. Physiol., 260, E459 Dokken, 2008, Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3, Am. J. Physiol. Endocrinol. Metab., 294, E615, 10.1152/ajpendo.00578.2007 Du, 2003, TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver, Science, 300, 1574, 10.1126/science.1079817 Duckworth, 1988, Insulin degradation: mechanisms, products, and significance, Endocr. Rev., 9, 319, 10.1210/edrv-9-3-319 Dutchak, 2012, Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones, Cell, 148, 556, 10.1016/j.cell.2011.11.062 Dutour, 2016, Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy, Diabetes Obes. Metab., 18, 882, 10.1111/dom.12680 Duvel, 2010, Activation of a metabolic gene regulatory network downstream of mTOR complex 1, Mol. Cell, 39, 171, 10.1016/j.molcel.2010.06.022 Elchebly, 1999, Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene, Science, 283, 1544, 10.1126/science.283.5407.1544 Emanuelli, 2001, SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-a in the adipose tissue of obese mice, J. Biol. Chem., 276, 47944, 10.1074/jbc.M104602200 Emanuelli, 2000, SOCS-3 is an insulin-induced negative regulator of insulin signaling, J. Biol. Chem., 275, 15985, 10.1074/jbc.275.21.15985 Eriksson, 2018, Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study, Diabetologia, 61, 1923, 10.1007/s00125-018-4675-2 Evans, 2005, The molecular basis for oxidative stress-induced insulin resistance, Antioxidants Redox Signal., 7, 1040, 10.1089/ars.2005.7.1040 Fabbrini, 2009, Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity, Proc. Natl. Acad. Sci. U. S. A., 106, 15430, 10.1073/pnas.0904944106 Fan, 2010, Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor a- and interleukin-1b-induced IKK/NF-kB and JNK/AP-1 activation, J. Biol. Chem., 285, 5347, 10.1074/jbc.M109.076976 Farese, 2007, Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes, J. Clin. Investig., 117, 2289, 10.1172/JCI31408 Farese, 2010, Metabolic functions of atypical protein kinase C: “Good” and “bad” as defined by nutritional status, Am. J. Physiol. Endocrinol. Metab., 298, E385, 10.1152/ajpendo.00608.2009 Finck, 2015, Does diacylglycerol accumulation in fatty liver disease cause hepatic insulin resistance?, BioMed Res. Int., 2015, 104132, 10.1155/2015/104132 Fulcher, 1992, Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects, Diabetes, 41, 1400, 10.2337/diab.41.11.1400 Gaisano, 2017, Recent new insights into the role of SNA RE and associated proteins in insulin granule exocytosis, Diabetes Obes. Metab., 19, 115, 10.1111/dom.13001 Gandasi, 2017, Ca2+ channel clustering with insulin-containing granules is disturbed in type 2 diabetes, J. Clin. Investig., 127, 2353, 10.1172/JCI88491 Gao, 2002, Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex, J. Biol. Chem., 277, 48115, 10.1074/jbc.M209459200 Gao, 2003, Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases, J. Biol. Chem., 278, 24944, 10.1074/jbc.M300423200 Garvey, 1998, Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance, J. Clin. Investig., 101, 2377, 10.1172/JCI1557 Goldstein, 1998, Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases, Mol. Cell. Biochem., 182, 91, 10.1023/A:1006812218502 Goodner, 1988, Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes, Diabetes, 37, 1316, 10.2337/diab.37.10.1316 Gregoire, 2009, MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema, Mol. Endocrinol., 23, 975, 10.1210/me.2008-0473 Gruben, 2014, Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?, Biochim. Biophys. Acta, 1842, 2329, 10.1016/j.bbadis.2014.08.004 Guan, 2002, A futile metabolic cycle activated in adipocytes by antidiabetic agents, Nat. Med., 8, 1122, 10.1038/nm780 Guo, 2009, The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis, Mol. Cell. Biol., 29, 5070, 10.1128/MCB.00138-09 Haeusler, 2014, Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors, Nat. Commun., 5, 5190, 10.1038/ncomms6190 Hale, 2013, Insulin signalling to the kidney in health and disease, Clin. Sci. (Lond.), 124, 351, 10.1042/CS20120378 Han, 2015, The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1, Nature, 524, 243, 10.1038/nature14557 Handberg, 1993, Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, 36, 668, 10.1007/BF00404079 Hanke, 2009, The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2, Mol. Cell. Proteom., 8, 519, 10.1074/mcp.M800407-MCP200 Hanson, 1997, Regulation of phosphoenolpyruvatecarboxykinase (GTP) gene expression, Annu. Rev. Biochem., 66, 581, 10.1146/annurev.biochem.66.1.581 Hao, 2007, PAS kinase is required for normal cellular energy balance, Proc. Natl. Acad. Sci. U. S. A., 104, 15466, 10.1073/pnas.0705407104 Harriman, 2016, Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats, Proc. Natl. Acad. Sci. U. S. A., 113, E1796, 10.1073/pnas.1520686113 Haruta, 1995, Amplification and analysis of promoter region of insulin receptor gene in a patient with leprechaunism associated with severe insulin resistance, Metabolism, 44, 430, 10.1016/0026-0495(95)90048-9 Harwood, 2003, Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals, J. Biol. Chem., 278, 37099, 10.1074/jbc.M304481200 He, 2009, Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein, Cell, 137, 635, 10.1016/j.cell.2009.03.016 Himsworth, 1949, The syndrome of diabetes mellitus and its causes, Lancet, 253, 465, 10.1016/S0140-6736(49)90797-7 Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137 Holt, 2009, Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis, Mol. Endocrinol., 23, 1406, 10.1210/me.2008-0386 Honda, 2016, The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice, PLoS One, 11, 10.1371/journal.pone.0146337 Hosoi, 2010, Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice, PLoS One, 5, 10.1371/journal.pone.0012537 Hribal, 2008, Transgenic mice overexpressing human G972R IRS-1 showimpaired insulin action and insulin secretion, J. Cell Mol. Med., 12, 2096, 10.1111/j.1582-4934.2008.00246.x Huang, 2013, Insulin responsiveness of glucose transporter 4 in 3T3-L1 cells depends on the presence of sortilin, Mol. Biol. Cell, 24, 3115, 10.1091/mbc.e12-10-0765 Hultmark, 1994, Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family, Biochem. Biophys. Res. Commun., 199, 144, 10.1006/bbrc.1994.1206 Hwang, 2015, A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression, Biochem. Pharmacol., 98, 157, 10.1016/j.bcp.2015.08.098 Jager, 2007, Interleukin-1b-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression, Endocrinology, 148, 241, 10.1210/en.2006-0692 Jaldin-Fincati, 2017, Update on GLUT4 vesicle traffic: a cornerstone of insulin action, Trends Endocrinol. Metab., 28, 597, 10.1016/j.tem.2017.05.002 Janani, 2015, PPAR gamma gene--a review, Diabetes Metab. Syndr., 9, 46, 10.1016/j.dsx.2014.09.015 Jia, 2014, Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance, Nat. Commun., 5, 3878, 10.1038/ncomms4878 Jornayvaz, 2012, Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance, Cell Metabol., 15, 574, 10.1016/j.cmet.2012.03.005 Jung, 2018, Adapting to insulin resistance in obesity: role of insulin secretion and clearance, Diabetologia, 61, 681, 10.1007/s00125-017-4511-0 Kagawa, 2008, Impact of transgenic overexpression of SH2-containing inositol 50- phosphatase 2 on glucose metabolism and insulin signaling in mice, Endocrinology, 149, 642, 10.1210/en.2007-0820 Kahn, 1996, Glucose transport: pivotal step in insulin action, Diabetes, 45, 1644, 10.2337/diab.45.11.1644 Kahn, 1976, The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man, N. Engl. J. Med., 294, 739, 10.1056/NEJM197604012941401 Kamei, 2006, Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance, J. Biol. Chem., 281, 26602, 10.1074/jbc.M601284200 Kern, 2016, The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin, Metabolism, 65, 114, 10.1016/j.metabol.2015.10.010 Kikani, 2019, PASsing on signals: PAS kinase (PASK)-mTOR signaling conveys nutrient sufficiency signals to epigenetic (COMPASS) complexes to activate stem cell differentiation program (P15-009-19), Curr. Dev. Nutr., 3 Kim, 2000, Mechanism of insulin resistance in A-ZIP/F-1 fatless mice, J. Biol. Chem., 275, 8456, 10.1074/jbc.275.12.8456 Kim, 2017, Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models, Arch Pharm. Res. (Seoul), 40, 268, 10.1007/s12272-016-0864-z Kitamura, 1999, Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serinethreonine kinase Akt, Mol. Cell. Biol., 19, 6286, 10.1128/MCB.19.9.6286 Klaman, 2000, Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in proteintyrosine phosphatase 1B-deficient mice, Mol. Cell. Biol., 20, 5479, 10.1128/MCB.20.15.5479-5489.2000 Kleinridders, 2014, Insulin action in brain regulates systemic metabolism and brain function, Diabetes, 63, 2232, 10.2337/db14-0568 Klip, 2014, Signal transduction meets vesicle traffic: the software and hardware of GLUT4 translocation, Am. J. Physiol. Cell Physiol., 306, C879, 10.1152/ajpcell.00069.2014 Klover, 2004, Hepatocytes: critical for glucose homeostasis, Int. J. Biochem. Cell Biol., 36, 753, 10.1016/j.biocel.2003.10.002 Koffler, 1989, Insulin resistance and diabetes, mechanism and possible intervention, Diabetes Res. Clin. Pract., 7, 83, 10.1016/0168-8227(89)90098-3 Kolman, 2009, Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro, Am. J. Physiol. Renal. Physiol., 296, F1227, 10.1152/ajprenal.90351.2008 Komiya, 2016, Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction, PLoS One, 11, 10.1371/journal.pone.0151511 Konner, 2012, Selective insulin and leptin resistance in metabolic disorders, Cell Metabol., 16, 144, 10.1016/j.cmet.2012.07.004 Koo, 2004, PGC-1 promotes insulin resistance in liver through PPAR-a-dependent induction of TRB-3, Nat. Med., 10, 530, 10.1038/nm1044 Kowalski, 2014, The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents, Am. J. Physiol. Endocrinol. Metab., 307, E859, 10.1152/ajpendo.00165.2014 Kowluru, 2012, Hyperactivation of protein phosphatase 2A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences, Biochem. Pharmacol., 84, 591, 10.1016/j.bcp.2012.05.003 Kraegen, 1991, Development of muscle insulin resistance after liver insulin resistance in high fat- fed rats, Diabetes, 40, 1397, 10.2337/diab.40.11.1397 Kubota, 2008, Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding, Cell Metabol, 8, 49, 10.1016/j.cmet.2008.05.007 Kumashiro, 2011, Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease, Proc. Natl. Acad. Sci. U.S.A., 108, 16381, 10.1073/pnas.1113359108 Kuo, 2011, Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse, Diabetologia, 54, 168, 10.1007/s00125-010-1931-5 Kurlawalla-Martinez, 2005, Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue, Mol. Cell. Biol., 25, 2498, 10.1128/MCB.25.6.2498-2510.2005 Lallukka, 2016, Non-alcoholic fatty liver disease and risk of type 2 diabetes, Best Pract. Res. Clin. Endocrinol. Metabol., 30, 385, 10.1016/j.beem.2016.06.006 Lam, 2002, Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta, Am. J. Physiol. Endocrinol. Metab., 283, E682, 10.1152/ajpendo.00038.2002 Lamming, 2012, Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity, Science, 335, 1638, 10.1126/science.1215135 Latva-Rasku, 2019, The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients, Diabetes Care, 42, 931, 10.2337/dc18-1569 Lautte, 2002, New paradigm for the mechanism and treatment of insulin resistance proc. West, Pharmacol. Soc., 45, 223 Leavens, 2011, Insulin signaling to hepatic lipid metabolism in health and disease, Crit. Rev. Biochem. Mol. Biol., 46, 200, 10.3109/10409238.2011.562481 Lee, 2018, CREB/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis, FASEB J., 32, 1566, 10.1096/fj.201700845R Lee, 2016, Insulin in the nervous system and the mind: functions in metabolism, memory, and mood, Mol. Metab., 5, 589, 10.1016/j.molmet.2016.06.011 Li, 2011, Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity, Cell, 147, 815, 10.1016/j.cell.2011.09.050 Li, 2010, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis, Proc. Natl. Acad. Sci. U. S. A, 107, 3441, 10.1073/pnas.0914798107 Li, 2007, Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1a cription coactivator, Nature, 447, 1012, 10.1038/nature05861 Liang, 2014, Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation, Lab. Investig., 94, 491, 10.1038/labinvest.2014.11 Lim, 2009, Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat, Obesity, 17, 188, 10.1038/oby.2008.486 Lin, 2011, Hormonal regulation of hepatic glucose production in health and disease, Cell Metabol., 14, 9, 10.1016/j.cmet.2011.06.003 Loomba, 2012, Nonalcoholic Steatohepatitis Clinical Research Network. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis, Hepatology, 56, 943, 10.1002/hep.25772 Lu, 2012, Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1, Nat. Med., 18, 388, 10.1038/nm.2686 Ma, 2006, Farnesoid X receptor is essential for normal glucose homeostasis, J. Clin. Investig., 116, 1102, 10.1172/JCI25604 Massillon, 1996, Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats, J. Biol. Chem., 271, 9871, 10.1074/jbc.271.17.9871 Matsumoto, 2003, PKCl in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity, J. Clin. Investig., 112, 935, 10.1172/JCI200318816 McDonald, 2009, Control of insulin granule dynamics by AMPK dependent KLC1 phosphorylation, Islets, 1, 198, 10.4161/isl.1.3.9608 Meier, 2005, Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans, Diabetes, 54, 1649, 10.2337/diabetes.54.6.1649 Michael, 2000, Loss of insulin signalling in hepatocyes leads tosevere insulin resistance and progressive hepatic dysfunction, Mol. Cell, 6, 87, 10.1016/S1097-2765(05)00015-8 Millward, 1999, Regulation of protein kinase cascades by protein phosphatase 2A, Trends Biochem. Sci., 24, 186, 10.1016/S0968-0004(99)01375-4 Minehira, 2008, Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice, J. Lipid Res., 49, 2038, 10.1194/jlr.M800248-JLR200 Misra, 2007, The role of AMP kinase in diabetes, Indian J. Med. Res., 125, 389 Mithieux, 1996, Glucose-6-phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats, Diabetes, 45, 891, 10.2337/diab.45.7.891 Miura, 2010, Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice, Gastroenterology, 139, 323, 10.1053/j.gastro.2010.03.052 Miyazaki, 2012, Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism, Mol. Med. Rep., 5, 729 Monetti, 2007, Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver, Cell Metabol., 6, 69, 10.1016/j.cmet.2007.05.005 Mu, 2019, Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues, Front. Pharmacol., 9, 1566, 10.3389/fphar.2018.01566 Mudaliar, 2001, New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers, Annu. Rev. Med., 52, 239, 10.1146/annurev.med.52.1.239 Myers, 1992, IRS-1 activates phosphatidylinositol 30-kinase by associating with src homology 2 domains of p85, Proc. Natl. Acad. Sci., 89, 10350, 10.1073/pnas.89.21.10350 Nagarajan, 2016, MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels, Nat. Commun., 7, 12639, 10.1038/ncomms12639 Najjar, 2002, Regulation of insulin action by CEA CAM1, Trends Endocrinol. Metab., 13, 240, 10.1016/S1043-2760(02)00608-2 Nakamura, 2017, A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice, Int. J. Mol. Med., 39, 969, 10.3892/ijmm.2017.2899 Ni, 2007, FoxO cription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases, Proc. Natl. Acad. Sci., 104, 20517, 10.1073/pnas.0610290104 Nielsen, 1987, Luminal and basolateral uptake of insulin in isolated, perfused, proximal tubules, Am. J. Physiol., 253, F857 Oh, 2011, mTOR complex 2 signaling and functions, Cell Cycle, 10, 2305, 10.4161/cc.10.14.16586 Olefsky, 1982, Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus, Am. J. Physiol. Endocrinol. Metab., 243, E15, 10.1152/ajpendo.1982.243.1.E15 Olefsky, 1990, The insulin receptor. A multifunctional protein, Diabetes, 39, 1009, 10.2337/diab.39.9.1009 Otero, 2014, Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux, J. Biol. Chem., 289, 20462, 10.1074/jbc.R114.576355 Palmer, 1988, Vascular endothelial cells synthesize nitric oxide from L-arginine, Nature, 333, 664, 10.1038/333664a0 Park, 2010, The regulatory subunits of PI3K, p85a and p85b, interact with XBP-1 and increase its nuclear translocation, Nat. Med., 16, 429, 10.1038/nm.2099 Pearce, 2010, The nuts and bolts of AGC protein kinases, Nat. Rev. Mol. Cell Biol., 11, 9, 10.1038/nrm2822 Perry, 2015, Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes, Cell, 160, 745, 10.1016/j.cell.2015.01.012 Perry, 2014, The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes, Nature, 510, 84, 10.1038/nature13478 Petersen, 2016, Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance, J. Clin. Investig., 126, 4361, 10.1172/JCI86013 Poy, 2002, CEA CAM1 regulates insulin clearance in liver, Nat. Genet., 30, 270, 10.1038/ng840 Puhakainen, 1993, Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM, Diabetes, 42, 1694, 10.2337/diab.42.12.1694 Qiang, 2015, Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus, Diabetol. Metab. Syndrome, 7, 104, 10.1186/s13098-015-0102-8 Rabinowitz, 1962, Role of free fatty acids in forearm metabolism in man, quantitated by use of insulin, J. Clin. Investig., 41, 2191, 10.1172/JCI104678 Rabkin, 1984, The renal metabolism of insulin, Diabetologia, 27, 351, 10.1007/BF00304849 Ravnskjaer, 2013, Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects, J. Clin. Investig., 123, 4318, 10.1172/JCI69035 Rebrin, 1995, Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin, Diabetes, 44, 1038, 10.2337/diab.44.9.1038 Rorsman, 2003, Insulin granule dynamics in pancreatic beta cells, Diabetologia, 46, 1029, 10.1007/s00125-003-1153-1 Rotter, 2003, Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-a, overexpressed in human fat cells from insulin-resistant subjects, J. Biol. Chem., 278, 45777, 10.1074/jbc.M301977200 Rui, 2002, SOCS-1 and SOCS-3 block insulin signaling by ubiquitin- mediated degradation of IRS1 and IRS2, J. Biol. Chem., 277, 42394, 10.1074/jbc.C200444200 Russo, 2017, Liver-specific reconstitution of CEA CAM1 reverses the metabolic abnormalities caused by its global deletion in male mice, Diabetologia, 60, 2463, 10.1007/s00125-017-4432-y Sachithanandan, 2010, Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity, Hepatology, 52, 1632, 10.1002/hep.23861 Sakamoto, 2008, Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic, Am. J. Physiol. Endocrinol. Metab., 295, E29, 10.1152/ajpendo.90331.2008 Samuel, 2007, Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease, J. Clin. Investig., 117, 739, 10.1172/JCI30400 Samuel, 2016, The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux, J. Clin. Investig., 126, 12, 10.1172/JCI77812 Samuel, 2012, Mechanisms for insulin resistance: common threads and missing links, Cell, 148, 852, 10.1016/j.cell.2012.02.017 Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science, 307, 1098, 10.1126/science.1106148 Scheen, 2019, Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: a common comorbidity associated with severe complications, Diabetes Metab., 45, 213, 10.1016/j.diabet.2019.01.008 Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, J. Clin. Investig., 118, 2992, 10.1172/JCI34260 Schultze, 2011, Promiscuous affairs of PKB/AKT isoforms in metabolism, Arch. Physiol. Biochem., 117, 70, 10.3109/13813455.2010.539236 Schwartz, 2000, Central nervous system control of food intake, Nature, 404, 661, 10.1038/35007534 Sears, 2015, The role of fatty acids in insulin resistance, Lipids Health Dis., 14, 121, 10.1186/s12944-015-0123-1 Shaw, 2011, The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer, Cell Cycle, 10, 1750, 10.4161/cc.10.11.15824 Shimizu, 2019, Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease, Diabetes Obes. Metab., 21, 285, 10.1111/dom.13520 Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice, Mol. Cell, 6, 77, 10.1016/S1097-2765(05)00010-9 Shiura, 2005, Meg 1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades, Biochem. Biophys. Res. Commun., 329, 909, 10.1016/j.bbrc.2005.02.047 Shoelson, 2003, Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance, Int. J. Obes. Relat. Metab. Disord., 27, S49, 10.1038/sj.ijo.0802501 Sindelar, 1997, The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog, Diabetes, 46, 187, 10.2337/diab.46.2.187 Sinha, 2004, Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor k B, J. Biol. Chem., 279, 41294, 10.1074/jbc.M406514200 Sleeman, 2005, Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity, Nat. Med., 11, 199, 10.1038/nm1178 Smith, 2007, Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life, Mol. Cell. Biol., 27, 5871, 10.1128/MCB.02087-06 Soli, 1975, Insulin receptor deficiency in genetic and acquired obesity, J. Clin. Investig., 56, 769, 10.1172/JCI108155 Soll, 1975, Insulin binding to liver plasm membranes in the obese hyperglycemic (ob/ob) mouse. Demonstration of a decreased number of functionally normal receptors, J. Biol. Chem., 250, 4702, 10.1016/S0021-9258(19)41358-6 Song, 2000, Direct measurement of pulsatile insulin secretion from the portal vein in human subjects, J. Clin. Endocrinol. Metab., 85, 4491 Steinberg, 1994, Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release, J. Clin. Investig., 94, 1172, 10.1172/JCI117433 Stevenson, 1985, The relationship between plasma concentration and disappearance rate of immunoreactive insulin in the conscious dog, Horm. Metab. Res., 17, 551, 10.1055/s-2007-1013604 Sumida, 2019, Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: a prospective, single-arm trial (LEAD trial), 714 Hepatol. Res., 49, 64, 10.1111/hepr.13236 Sun, 2002, Phosphoenol pyruvate carboxykinase overexpression selectively attenuates insulin signalling and hepatic insulin sensitivity in transgenic mice, J. Biol. Chem., 277, 23301, 10.1074/jbc.M200964200 Suwa, 2010, SHIP2 and its involvement in various diseases, Expert Opin. Ther. Targets, 14, 727, 10.1517/14728222.2010.492780 Tahara, 2013, Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice, Eur. J. Pharmacol., 715, 246, 10.1016/j.ejphar.2013.05.014 Tak, 2001, NF-kappaB: a key role in inflammatory diseases, J. Clin. Investig., 107, 7, 10.1172/JCI11830 Taniguchi, 2010, The phosphoinositide 3-kinase regulatory subunit p85a can exert tumor suppressor properties through negative regulation of growth factor signaling, Cancer Res., 70, 5305, 10.1158/0008-5472.CAN-09-3399 Taylor, 1991, Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance, Adv. Exp. Med. Biol., 293, 197, 10.1007/978-1-4684-5949-4_19 Terauchi, 1999, Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 a subunit of phosphoinositide 3-kinase, Nat. Genet., 21, 230, 10.1038/6023 Teruel, 2001, Ceramide mediates insulin resistance by tumor necrosis factor-a in brown adipocytes by maintaining Akt in an inactive dephosphorylated state, Diabetes, 50, 2563, 10.2337/diabetes.50.11.2563 Titchenell, 2015, Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo, Nat. Commun., 6, 7078, 10.1038/ncomms8078 Titchenell, 2016, Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production, Cell Metabol., 23, 1154, 10.1016/j.cmet.2016.04.022 Tokarz, 2018, The cell biology of systemic insulin function, J. Cell Biol., 217, 2273, 10.1083/jcb.201802095 Trinh, 1998, Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats, J. Biol. Chem., 273, 31615, 10.1074/jbc.273.47.31615 Tzivion, 2011, FoxO cription factors; Regulation by AKT and 14–3-3 proteins, Biochim. Biophys. Acta, 1813, 1938, 10.1016/j.bbamcr.2011.06.002 Ueki, 2004, Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms, Mol. Cell. Biol., 24, 5434, 10.1128/MCB.24.12.5434-5446.2004 Ueki, 2004, Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse, Proc. Natl. Acad. Sci., 101, 10422, 10.1073/pnas.0402511101 Ueki, 2002, Increased insulin sensitivity in mice lacking p85b subunit of phosphoinositide 3-kinase, Proc. Natl. Acad. Sci., 99, 419, 10.1073/pnas.012581799 Uysal, 1997, Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function, Nature, 389, 610, 10.1038/39335 Vaag, 1991, Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus, J. Clin. Investig., 88, 1282, 10.1172/JCI115432 Vaidya, 2012, Anti-diabetic activity of swertiamarin is due to an active metabolite, gentianine, that upregulates PPAR-Γ gene expression in 3t3-L1 cells, Phyother. Res., 27, 624, 10.1002/ptr.4763 Vaidya, 2012, Beneficial effects of swertiamarin on dyslipidaemia in streptozotocin-induced type 2 diabetic rats, Phytother Res., 26, 1259, 10.1002/ptr.3708 Vaidya, 2014, Acetylated and propionated derivatives of swertiamarin have anti-adipogenic effects, J. Pharmacol. Pharmacother., 5, 232, 10.4103/0976-500X.142429 Valera, 1994, Transgenic mice overexpressing phosphoenolpyruvatecarboxykinase develop non-insulin-dependent diabetes mellitus, Proc. Natl. Acad. Sci., 91, 9151, 10.1073/pnas.91.19.9151 Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40, Nat. Cell Biol., 9, 316, 10.1038/ncb1547 Vassilopoulos, 2009, A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism, Science, 324, 1192, 10.1126/science.1171529 Vincent, 2002, Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow, Diabetes, 51, 42, 10.2337/diabetes.51.1.42 Vingtdeux, 2011, Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation, FASEB J., 25, 219, 10.1096/fj.10-167361 Wakil, 2009, Fatty acid metabolism: target for metabolic syndrome, J. Lipid Res., S138– S143 Wang, 2007, Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo, Mol. Cell. Biol., 27, 6497, 10.1128/MCB.00679-07 Wei, 2016, HNF-4α regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in Type 2 diabetic mice and in palmitate-treated HepG2 cells, Eur. J. Pharmacol., 791, 254, 10.1016/j.ejphar.2016.08.038 Westwick, 1995, Ceramide activates the stress-activated protein kinases, J. Biol. Chem., 270, 22689, 10.1074/jbc.270.39.22689 Wijesekara, 2005, Muscle-specific Pten deletion protects against insulin resistance and diabetes, Mol. Cell. Biol., 25, 1135, 10.1128/MCB.25.3.1135-1145.2005 Winder, 1999, AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes, Am. J. Physiol. Endocrinol. Metab., 277, E1, 10.1152/ajpendo.1999.277.1.E1 Winnay, 2010, A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response, Nat. Med., 16, 438, 10.1038/nm.2121 Wong, 2009, A role of DNA-PK for the metabolic gene regulation in response to insulin, Cell, 136, 1056, 10.1016/j.cell.2008.12.040 Woods, 2003, Insulin and the blood-brain barrier, Curr. Pharmaceut. Des., 9, 795, 10.2174/1381612033455323 Worm, 1994, Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period, J. Clin. Endocrinol. Metab., 78, 717 Wu, 2012, NOX4 pathway as a source of selective insulin resistance and responsiveness, Arterioscler. Thromb. Vasc. Biol., 32, 1236, 10.1161/ATVBAHA.111.244525 Yalow, 1960, Immunoassay of endogenous plasma insulin in man, J. Clin. Investig., 39, 10.1172/JCI104130 Yamauchi, 2001, The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARγ agonist improve insulin resistance, J. Biol. Chem., 276, 41245, 10.1074/jbc.M103241200 Yang, 2018, Metabolites as regulators of insulin sensitivity and metabolism, Nat. Rev. Mol. Cell Biol., 19, 654, 10.1038/s41580-018-0044-8 Yu, 2002, Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)- associated phosphatidylinositol 3-kinase activity in muscle, J. Biol. Chem., 277, 50230, 10.1074/jbc.M200958200 Zeng, 2000, Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells, Circulation, 101, 1539, 10.1161/01.CIR.101.13.1539 Zhang, 2012, Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signalling, Proc. Natl. Acad. Sci., 109, 1667, 10.1073/pnas.1110730109 Zhang, 2008, S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-a signaling through IKK2, J. Biol. Chem., 283, 35375, 10.1074/jbc.M806480200 Zhang, 2006, Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice, Proc. Natl. Acad. Sci. U. S. A., 103, 1006, 10.1073/pnas.0506982103 Zheng, 2018, Dipeptidyl-peptidase 4 inhibitor sitagliptin ameliorates hepatic insulin resistance by modulating inflammation and autophagy in ob/ob mice, Internet J. Endocrinol., 2018, 8309723 Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J. Clin. Investig., 108, 1167, 10.1172/JCI13505 Zhuge, 2016, DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization, Diabetes, 65, 2966, 10.2337/db16-0317